By Howard Wolinsky

Artificial Intelligence is the buzz throughout the prostate cancer world. An AI expert will be featured at the Active Surveillance ‘25 event to discuss what’s new in low-risk disease at noon Eastern on Saturday, Jan. 24, 2025.

Tim Showalter, MD, MPH, Chief Medical Officer of ArteraAI, the leading AI firm, will join the panel and discus…